Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read More